StockData
Annexon, Inc. logo

Annexon, Inc. (ANNX) stock

ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$3.57−0.35 (-8.93%)

Close on Nov 16, 2026Market cap $729.87MP/E –Yield 0.00%

Annexon total assets

Total assets on the balance sheet at the end of each period.

Annexon's total assets was $246.07M at Jun 30, 2026. For fiscal 2025 it was $277.57M, down 20.7% from the year before. The highest annual figure on record is $355.95M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$277.57M-20.7%
FY2024Dec 31, 2024$350.07M+17.6%
FY2023Dec 31, 2023$297.67M+4.4%
FY2022Dec 31, 2022$285.10M-0.7%
FY2021Dec 31, 2021$287.04M-19.4%
FY2020Dec 31, 2020$355.95M+613.3%
FY2019Dec 31, 2019$49.90M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$246.07M-7.0%
Q1 FY2026Mar 31, 2026$262.89M-13.2%
Q4 FY2025Dec 31, 2025$277.57M-20.7%
Q3 FY2025Sep 30, 2025$229.14M-39.5%
Q2 FY2025Jun 30, 2025$264.57M-34.8%
Q1 FY2025Mar 31, 2025$303.03M-0.3%
Q4 FY2024Dec 31, 2024$350.07M+17.6%
Q3 FY2024Sep 30, 2024$378.78M+85.8%
Q2 FY2024Jun 30, 2024$406.09M+74.3%
Q1 FY2024Mar 31, 2024$304.07M+13.1%
Q4 FY2023Dec 31, 2023$297.67M+4.4%
Q3 FY2023Sep 30, 2023$203.82M-34.8%
Q2 FY2023Jun 30, 2023$233.01M+5.6%
Q1 FY2023Mar 31, 2023$268.78M+7.3%
Q4 FY2022Dec 31, 2022$285.10M-0.7%
Q3 FY2022Sep 30, 2022$312.72M+0.8%
Q2 FY2022Jun 30, 2022$220.70M-33.5%
Q1 FY2022Mar 31, 2022$250.57M-24.8%
Q4 FY2021Dec 31, 2021$287.04M-19.4%
Q3 FY2021Sep 30, 2021$310.16M-17.4%
Q2 FY2021Jun 30, 2021$331.78M+153.1%
Q1 FY2021Mar 31, 2021$333.12M+567.6%
Q4 FY2020Dec 31, 2020$355.95M–
Q3 FY2020Sep 30, 2020$375.61M–
Q2 FY2020Jun 30, 2020$131.09M–
Q4 FY2019Dec 31, 2019$49.90M–

More Annexon figures

See a number that looks wrong?